Generic Zituvimet XR Availability
Last updated on Jun 11, 2025.
See also: Generic Zituvimet
Zituvimet XR is a brand name of metformin/sitagliptin, approved by the FDA in the following formulation(s):
ZITUVIMET XR (metformin hydrochloride; sitagliptin - tablet, extended release;oral)
-
Manufacturer: ZYDUS LIFESCIENCES
Approval date: July 18, 2024
Strength(s): 1GM;50MG [RLD], 1GM;100MG [RLD], 500MG;50MG [RLD]
Is there a generic version of Zituvimet XR available?
An Authorized Generic version of Zituvimet XR has been approved. An Authorized Generic is a prescription drug that is produced by a brand company under a New Drug Application (NDA) and marketed as a generic under a private label. It is identical to the branded product in appearance and has exactly the same inactive ingredients.
List of authorized generic versions:
- sitagliptin and metformin hydrochloride ORAL TABLET, FILM COATED, EXTENDED RELEASE 500; 50 mg/1; mg
Zydus Pharmaceuticals USA Inc.
NDC Code: 707102036 - sitagliptin and metformin hydrochloride ORAL TABLET, FILM COATED, EXTENDED RELEASE 1000; 50 mg/1; mg
Zydus Pharmaceuticals USA Inc.
NDC Code: 707102037 - sitagliptin and metformin hydrochloride ORAL TABLET, FILM COATED, EXTENDED RELEASE 1000; 100 mg/1; mg
Zydus Pharmaceuticals USA Inc.
NDC Code: 707102038 - sitagliptin and metformin hydrochloride ORAL TABLET, FILM COATED, EXTENDED RELEASE 1000; 50 mg/1; mg
Zydus Lifesciences Limited
NDC Code: 707711886 - sitagliptin and metformin hydrochloride ORAL TABLET, FILM COATED, EXTENDED RELEASE 500; 50 mg/1; mg
Zydus Lifesciences Limited
NDC Code: 707711887 - sitagliptin and metformin hydrochloride ORAL TABLET, FILM COATED, EXTENDED RELEASE 1000; 100 mg/1; mg
Zydus Lifesciences Limited
NDC Code: 707711888
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zituvimet XR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Zituvimet XR (metformin / sitagliptin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiabetic combinations
- En español
Patient resources
Other brands
Janumet, Janumet XR, Zituvimet
Professional resources
Other brands
Janumet, Janumet XR, Zituvimet
Related treatment guides
Related/similar drugs
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.